Leptin receptor variant in women with polycystic ovary syndrome

Slides:



Advertisements
Similar presentations
Validation of a prediction model for the follicle-stimulating hormone response dose in women with polycystic ovary syndrome  Madelon van Wely, Ph.D.,
Advertisements

Clinically significant and sustained weight loss is achievable in obese women with polycystic ovary syndrome followed in a regular medical practice  Lysanne.
Andrew J. Krentz, M.D., Elizabeth Barrett-Connor, M.D. 
A new ultrasound criterion for the diagnosis of polycystic ovary syndrome: the ovarian stroma/total area ratio  Anna Maria Fulghesu, M.D., Mario Ciampelli,
PROGINS receptor gene polymorphism is associated with endometriosis
Association of insulin receptor genetic variants with polycystic ovary syndrome in a population of women from Central Europe  Felicia A. Hanzu, M.D.,
The antiandrogenic effect of flutamide improves uterine perfusion in women with polycystic ovary syndrome  Silvia Ajossa, M.D., Stefano Guerriero, M.D.,
Increased prevalence of anxiety symptoms in women with polycystic ovary syndrome: systematic review and meta-analysis  Anuja Dokras, M.D., Ph.D., Shari.
Risk of obstructive sleep apnea in obese and nonobese women with polycystic ovary syndrome and healthy reproductively normal women  Babak Mokhlesi, M.D.,
Serum levels of inhibins are differentially altered in patients with polycystic ovary syndrome: effects of being overweight and relevance to hyperandrogenism 
Michal Youngster, M. D. , Valerie L. Ward, M. D. , M. P. H. , Emily A
Metformin administration modulates and restores luteinizing hormone spontaneous episodic secretion and ovarian function in nonobese patients with polycystic.
Serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 (IGFBP-3) in IVF patients with polycystic ovary syndrome: correlations with outcome 
Continuing metformin throughout pregnancy in women with polycystic ovary syndrome appears to safely reduce first-trimester spontaneous abortion: a pilot.
Insulin resistance in oligomenorrheic infertile women with non-polycystic ovary syndrome  Shirei Ohgi, M.D., Koji Nakagawa, M.D., Ph.D., Rieko Kojima,
Risk of depression and other mental health disorders in women with polycystic ovary syndrome: a longitudinal study  Angela Kerchner, B.A., Whitney Lester,
Evaluation of the immature human oocytes from unstimulated cycles in polycystic ovary syndrome patients using a novel scoring system  Shan Liu, M.D.,
A randomized trial of the effects of two types of short-term hypocaloric diets on weight loss in women with polycystic ovary syndrome  Kelly Stamets,
CYP19 gene: a genetic modifier of polycystic ovary syndrome phenotype
Follicle-stimulating hormone receptor polymorphism (Thr307Ala) is associated with variable ovarian response and ovarian hyperstimulation syndrome in Indian.
Evolutionary determinants of polycystic ovary syndrome: part 1
The first successful paternity through in vitro fertilization–intracytoplasmic sperm injection with a man homozygous for the 5α-reductase-2 gene mutation 
Letrozole versus combined metformin and clomiphene citrate for ovulation induction in clomiphene-resistant women with polycystic ovary syndrome: a randomized.
Clinical course of depression symptoms and predictors of enduring depression risk in women with polycystic ovary syndrome: Results of a longitudinal study 
Serum soluble leptin receptor levels and free leptin index in women with polycystic ovary syndrome: relationship to insulin resistance and androgens 
A microsatellite polymorphism (tttta)n in the promoter of the CYP11a gene in Chinese women with polycystic ovary syndrome  Yong Wang, Ph.D., XiaoKe Wu,
Pernille Fog Svendsen, M. D. , Michael Christiansen, M. D
Andrew C. Bjonnes, M.S., Richa Saxena, Ph.D., Corrine K. Welt, M.D. 
From partner's desk to iPad
Effects of laparoscopic ovarian drilling on serum vascular endothelial growth factor and on insulin responses to the oral glucose tolerance test in women.
Hélio Sato, M. D. , Ph. D. , Naiara C. Nogueira-de-Souza, M. Sc. , Ph
Increased secretion of amylin in women with polycystic ovary syndrome
Correlations between concentrations of interleukin-12 and interleukin-13 and lymphocyte subsets in the follicular fluid of women with and without polycystic.
Massimo Tartagni, M. D. , Luca Maria Schonauer, M. D
Relationship between serum leptin concentrations and bone mineral density as well as biochemical markers of bone turnover in women with postmenopausal.
Imran Pirwany, MD, Togas Tulandi, MD  Fertility and Sterility 
Fleur R. Cattrall, M. B. B. S. , Beverley J. Vollenhoven, M. B. B. S
Luteal support with intravaginal progesterone increases clinical pregnancy rates in women with polycystic ovary syndrome using letrozole for ovulation.
Concentration of vascular endothelial growth factor released by cultured human luteinized granulosa cells is higher in women with polycystic ovaries than.
Polymorphism T→C (−34 bp) of gene CYP17 promoter in Greek patients with polycystic ovary syndrome  Evanthia Diamanti-Kandarakis, M.D., Ph.D., Michael.
Cancer risk among infertile women with androgen excess or menstrual disorders (including polycystic ovary syndrome)  Louise A. Brinton, Ph.D., Kamran.
Evidence for competing effects of body mass, hyperinsulinemia, insulin resistance, and androgens on leptin levels among lean, overweight, and obese women.
Simvastatin improves biochemical parameters in women with polycystic ovary syndrome: results of a prospective, randomized trial  Antoni J. Duleba, M.D.,
Serum resistin levels in women with polycystic ovary syndrome
Pregnancy outcome in infertile patients with polycystic ovary syndrome who were treated with metformin  Samuel S. Thatcher, M.D., Ph.D., Elizabeth M.
Postprandial triglyceride response in patients with polycystic ovary syndrome: relationship with waist-to-hip ratio and insulin  Elsy Velázquez M, M.D.,
Detlef Pietrowski, Ph. D. , Clemens Tempfer, M. D
Manuel Maliqueo, Ph. D. , Bárbara Echiburú, Ph. D
Altered autophosphorylation of the insulin receptor in the ovary of a woman with polycystic ovary syndrome  Carlos Moran, M.D., Raquel Huerta, M.D., Barbara-Ann.
Association of increased total antioxidant capacity and anovulation in nonobese infertile patients with clomiphene citrate–resistant polycystic ovary.
Paolo Moghetti, M.D.  Fertility and Sterility 
Validation of a prediction model for the follicle-stimulating hormone response dose in women with polycystic ovary syndrome  Madelon van Wely, Ph.D.,
Are patients with idiopathic hirsutism (IH) insulin resistant
Spontaneous pregnancy in a patient who was homozygous for the Q106R mutation in the gonadotropin-releasing hormone receptor gene  Didier Dewailly, M.D.,
Follicle-stimulating hormone receptor gene mutations are rare in Japanese women with premature ovarian failure and polycystic ovary syndrome  Kenji Takakura,
Mutation analysis of the growth differentiation factor-9 and -9B genes in patients with premature ovarian failure and polycystic ovary syndrome  Koichi.
The luteinizing hormone β-subunit exon 3 (Gly102Ser) gene mutation is rare in Korean women with endometriosis and polycystic ovary syndrome  Nam Keun.
Shilin Zhang, M. D. , Tao Wang, M. D. , Jun Yang, M. D. , Zhuo Liu, M
Tsan-Hon Liou, M. D. , Ph. D. , Jen-Hung Yang, M. D. , Ph. D
Genotype analysis of the neuropeptide Y (NPY) Y1 and NPY Y5 receptor genes in gonadotropin-releasing hormone–dependent precocious gonadarche  Mandi Barker-Gibb,
Follicle-stimulating hormone receptor polymorphisms in women with normogonadotropic anovulatory infertility  Joop S.E Laven, Ph.D., Annemarie G.M.G.J.
Adiponectin levels reflect the different phenotypes of polycystic ovary syndrome: study in normal weight, normoinsulinemic patients  Artemis Karkanaki,
Endometrial gene expression in the window of implantation is altered in obese women especially in association with polycystic ovary syndrome  José Bellver,
Chenming Xu, Ph. D. , Bingsen Xu, M. Sc. , Hefeng Huang, M. D
Relation of intra-abdominal fat distribution to metabolic disorders in nonobese patients with polycystic ovary syndrome  Basak Yildirim, M.D., Nuran Sabir,
Diabetes mellitus and insulin resistance in mothers, fathers, sisters, and brothers of women with polycystic ovary syndrome: a systematic review and meta-analysis 
Sequence variation analysis of the prolactin receptor C-terminal region in women with premature ovarian failure  Anne Bachelot, M.D., Ph.D., Justine Bouilly,
Is there a role for diet in ameliorating the reproductive sequelae associated with chronic low-grade inflammation in polycystic ovary syndrome and obesity? 
Stephen J Winters, M. D. , Evelyn Talbott, David S Guzick, Ph. D. , M
Enrico Carmina, M.D., Rogerio A Lobo, M.D.  Fertility and Sterility 
Presentation transcript:

Leptin receptor variant in women with polycystic ovary syndrome Cemal Tamer Erel, M.D., Naci Cine, Ph.D., Koray Elter, M.D., Semih Kaleli, M.D., Levent Mehmet Senturk, M.D., Bulent Baysal, M.D.  Fertility and Sterility  Volume 78, Issue 6, Pages 1334-1335 (December 2002) DOI: 10.1016/S0015-0282(02)04352-2

FIGURE 1 Genotyping of the human leptin receptor gene. Lane I: patients who were homozygous for the mutation. Lane II: patients who were homozygous for the normal genotype. Lane III: patients who were heterozygous for the mutation. Sizes of DNA fragments are indicated on the right side of the figure. Erel. Leptin receptor variant in women with PCOS.Fertil Steril 2002. Fertility and Sterility 2002 78, 1334-1335DOI: (10.1016/S0015-0282(02)04352-2)